Thrombocytopenia, immunoglobulin treatment, and acute myocardial infarction: A case report

Angiology

Volumn 56, Issue 2, 2005, Pages 229-231

  Amit, Guy ^a   Yermiyahu, Tikva ^a   Gilutz, Harel ^a   Ilia, Reuben ^a   Zahger, Doron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IMMUNOGLOBULIN; NITRATE;

ACUTE HEART INFARCTION; ADULT; ANGIOGRAPHY; ARTICLE; CASE REPORT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; MALE; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SPLENECTOMY; ST SEGMENT ELEVATION; THORAX PAIN; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; IMMUNIZATION, PASSIVE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE; RISK FACTORS;

EID: 15544391159     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970505600215     Document Type: Article

References (13)

1. Koch CA, Archer TP, Kraut EH: Myocardial ischemia in a patient with chronic refractory idiopathic thrombocytopenic purpura. Arch Intern Med 157:2668, 1997.
2. Rand ML, Dean JA: Platelet function in autoimmune (idiopathic) thrombocytopenic purpura. Acta Paediatr 424(suppl):57-60, 1998.
3. Weiss EJ, Bray PF, Tayback M, et al: A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334:1090-1094, 1996.
4. Bussel JB, Kunicki TJ, Michelson AD: Platelets: New understanding of platelet glycoproteins and their role in disease. Hematology (Am Soc Hematol Educ Program), 2000, pp 222-240.
5. Li YH, Chen JH, Tsai WC, et al: Synergistic effect of thrombomodulin promoter-33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost 87:86-91, 2002.
6. Solomon DH, Stone PH, Glynn RJ, et al: Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol 38:969-976, 2001.
7. Braunwald E, Antman EM, Beaslry JW, et al: ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. Circulation 102:1193-1209, 2000.
8. Theroux P, Quimet H, McCans J, et al: Aspirin heparin or both to treat acute unstable angina. N Engl J Med 319:1105-1111, 1988.
9. Paolini R, Zamboni S, Ramazzina E, et al: Idiopathic thrombocytopenic purpura treated with steroid therapy does not prevent acute myocardial infarction: A case report. Blood Coagul Fibrinolysis 10:439-442, 1999.
10. Elkayam O, Paran D, Milo R, et al: Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases. Ann Rheum Dis 59:77-80, 2000.
11. Haplea SS, Farrar JT, Gibson GA, et al: Thromboembolic events associated with intravenous immunoglobulin therapy. Neurology 48:A54, 1997.
12. Reinhart WH, Berchtold PE: Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet 339:662-664, 1992.
13. http://www.theheart.org [Apr 22, 2002].